Superworth

GoodRx EPS GDRX

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
$0.04
Latest quarter, Q2 FY26
$0.02
−50% on a year earlier
Fiscal year 2025
$0.09
+80% on the year before

GoodRx's earnings per share was $0.04 over the twelve months to Jun 30, 2026, down 60% on a year earlier.

In its latest quarter, Q2 FY26, it was $0.02, down 50% on the same quarter a year before.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$0.09+80%
FY2024$0.05n/a
FY2023−$0.02n/a
FY2022−$0.07n/a
FY2021−$0.07n/a
FY2020−$0.80n/a
FY2019n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.02−50%$0.04
Q1 FY26$0.00−100%$0.06
Q4 FY25$0.02+0%$0.09
Q3 FY25$0.00−100%$0.09
Q2 FY25$0.04+100%$0.10
Q1 FY25$0.03n/a$0.08
Q4 FY24$0.02n/a$0.05
Q3 FY24$0.01n/a−$0.03
Q2 FY24$0.02−86%−$0.13
Q1 FY24$0.00n/a−$0.01
Q4 FY23−$0.06n/a−$0.02
Q3 FY23−$0.09n/a$0.04

Against its peers

Companies in Software - Application nearest GoodRx's size, closest first, today.

CompanyEPS, 12 monthsGrowth
GDRXGoodRx$0.04−60% a year
LZLegalzoom.Com$0.09−44% a year
UPWKUpwork$0.76−55% a year
HSTMHealthstream$0.72+7% a year
EVEREverQuote$3.08+148% a year
TASKTaskUs$1.16+68% a year
EVTCEVERTEC$1.54−27% a year
YEXTYext$0.19
MNTNMNTN$0.75
INODInnodata$1.32+2% a year
NRDSNerdwallet$0.89+44% a year
Peer median$0.82

Where GoodRx ranks

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on GoodRx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.